Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial

NCT: NCT02200705 · COMPLETED

NCT IDNCT02200705
StatusCOMPLETED
Start Date2014-10
Completion2024-05-26
SponsorIceCure Medical Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

To evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer .

Frequently Asked Questions

What is Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial?

Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial is a clinical trial registered under NCT02200705. Current status: COMPLETED.

What is the status of NCT02200705?

The current status of NCT02200705 (Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial) is: COMPLETED.

When did Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial start?

Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial started on 2014-10.

Related Devices

K183213IceSense 3, ProSense, MultiSenseIceCure Medical , Ltd. K240892XSense Cryoablation System with CryoprobesIceCure Medical , Ltd. K260377XSense Cryoablation System with CryoProbesIceCure Medical , Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑